Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rasco

Showing results (191-200 of 289) with videos related to

Pageof 29
Sort By:
ACS Medicinal Chemistry Letters|May 20, 2017
Transdermal Bioavailability in Rats of Lidocaine in the Forms of Ionic Liquids, Salts, and Deep EutecticPaula Berton, Kristin R Di Bona, Denise Yancey, et al.
Transplantation Proceedings|October 26, 2010
Survival after cardiac transplantation: influence of the previous cardiopathy in the recipientN Romero-Rodríguez, E Lage-Gallé, A Guisado-Rasco, et al.
Biological Trace Element Research|April 26, 2015
Trivalent Chromium has no Effect on Delaying Azoxymethane-Induced Colorectal Cancer in FVB/NJ MicePandora E White, Ge Deng, M Kaitlyn Kuykendall, et al.
Journal of Pain and Symptom Management|April 15, 2003
Three instruments to assess fatigue in children with cancer: the child, parent and staff perspectivesMarilyn J Hockenberry, Pamela S Hinds, Patrick Barrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid TumorsJessica J Tao, Nicholas A Cangemi, Vicky Makker, et al.
Investigational New Drugs|March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumorsMaxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2018
A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced MalignanciesDrew W Rasco, Kyriakos P Papadopoulos, Michael Pourdehnad, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2023
Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human studyCarla Biesdorf, Xiaowen Guan, Satya R Siddani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2023
First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid TumorsNehal J Lakhani, Drew Rasco, Hengbang Wang, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2021
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trialAmita Patnaik, Glen J Weiss, Drew W Rasco, et al.
Pageof 29

Showing results (191-200 of 289) with videos related to

Sort By:
Pageof 29
ACS Medicinal Chemistry Letters|May 20, 2017
Transdermal Bioavailability in Rats of Lidocaine in the Forms of Ionic Liquids, Salts, and Deep EutecticPaula Berton, Kristin R Di Bona, Denise Yancey, et al.
Transplantation Proceedings|October 26, 2010
Survival after cardiac transplantation: influence of the previous cardiopathy in the recipientN Romero-Rodríguez, E Lage-Gallé, A Guisado-Rasco, et al.
Biological Trace Element Research|April 26, 2015
Trivalent Chromium has no Effect on Delaying Azoxymethane-Induced Colorectal Cancer in FVB/NJ MicePandora E White, Ge Deng, M Kaitlyn Kuykendall, et al.
Journal of Pain and Symptom Management|April 15, 2003
Three instruments to assess fatigue in children with cancer: the child, parent and staff perspectivesMarilyn J Hockenberry, Pamela S Hinds, Patrick Barrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid TumorsJessica J Tao, Nicholas A Cangemi, Vicky Makker, et al.
Investigational New Drugs|March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumorsMaxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2018
A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced MalignanciesDrew W Rasco, Kyriakos P Papadopoulos, Michael Pourdehnad, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2023
Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human studyCarla Biesdorf, Xiaowen Guan, Satya R Siddani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2023
First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid TumorsNehal J Lakhani, Drew Rasco, Hengbang Wang, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2021
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trialAmita Patnaik, Glen J Weiss, Drew W Rasco, et al.
Pageof 29